乳腺癌患者的循环microRNA和血清蛋白:诊断相关性和等级特定的表达模式
Safinaz E El-Toukhy1, Heba K Nabih1, Mahmoud M Kamel2
1Department of Medical Biochemistry, Medical Research and Clinical Studies Institute, National Research Centre, Giza 12622, Egypt.
World journal of experimental medicine
|January 12, 2026
概括
循环中的微RNAs (miRNAs) 在乳腺癌诊断和分级方面表现有前途. 一组miRNA与瘤生物标志物相结合,为个性化的患者管理提供了更高的准确性.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 分子诊断学 分子诊断
背景情况:
- 乳腺癌显著导致女性癌症相关死亡率.
- 早期检测和准确诊断对于有效的乳腺癌管理至关重要.
研究的目的:
- 评估循环微RNA (miRNA) 和瘤生物标志物的诊断相关性,以对乳腺癌进行分类.
- 评估这些标记物的灵敏度和特异性,以区分乳腺癌等级.
主要方法:
- 在乳腺癌患者中分析了特定miRNAs (miR-21,miR-221,miR-1246,miR-145,miR-382) 和瘤生物标志物 (CA15-3,8-OHdG) 的异常表达.
- 使用接收器操作特征 (ROC) 曲线分析来确定诊断准确性.
主要成果:
- 在不同乳腺癌等级之间确定了不同的miRNA表达模式.
- 与对照组相比,在患者中观察到CA15-3和8-OHdG水平升高.
- miR-21和miR-1246在患者分化和等级分类方面表现出高的诊断能力.
- 微RNA和生物标记物的组合提高了诊断准确度和灵敏度.
结论:
- 循环的miRNAs显示出在通过瘤等级区分乳腺癌患者的显著潜力.
- 多分析液体活检方法,结合miRNAs,可以提高诊断准确性和个性化管理.
- 这些发现支持开发乳腺癌新型诊断策略.
相关概念视频
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K


